Define ACS
A spectrum of acute myocardial ischaemic states due to unstable plaque rupture and thrombosis in the epicardial coronary artery leading to reduced blood flow.
What are the the 3 major clinical subtypes of ACS?
What is unstable angina?
unstable plaque rupture and thrombosis leading to transient occlusion of artery.
What is NSTEMI?
What is STEMI?
Describe the major clinical features of ACS.
What are the ECG changes seen in unstable angina and NSTEMI?
What are the ECG changes seen in STEMI?
- pathological Q waves development
Describe the diagnosis of ACS
What is the non-pharmacological management of ACS?
Describe the immediate clinical management of STEMI?
What is the difference between the anti thrombotic and pro thrombotic system?
Anti thrombotic system - inactivities clotting factors and plasminogen fibrinolytic system dissolves blood clots.
Pro thrombotic system - platelet adhesion and aggregation and activation of coagulation cascade forms blood clots.
Give 2 named examples of anti platelet drugs used in ACS management.
Aspirin
Clopidogrel
What is the mechanism of action for the anti platelet drug Aspirin?
it inhibits the COX enzyme - inhibiting TXA2 synthesis to inhibit platelet activation and aggregation in response to plaque rupture.
What is the mechanism of action for the anti platelet drug Clopidogrel?
inhibits ADP-R inhibiting platelet activation and aggregation in response to plaque rupture
Give 2 named examples of anti coagulant drugs used in ACS management.
UF heparin
Bivalrudin
What is the mechanism of action for the anti coagulant drug UF heparin?
indirect thrombin inhibitor - activates anti thrombotic system which inactivates FIIa, FXa, FIXa inhibiting the coagulation cascade.
What is the mechanism of action for the anti coagulant drug Bivalrudin?
Direct thrombin inactivator - inactivates FIIa
Give named examples of the 2 classes of thrombolytic drugs and describe their mechanism of action for thrombolytic therapy used in ACS management.
Activation of plasminogen fibrinolytic system to dissolve blood clot in infarct-related coronary artery and restore blood flow.
SK - indirectly-acting plasminogen activator
T-PAs - directly acting plasminogen activators - alteplase, reteplase, tenecteplase
Clot selective and fibrin-enhanced conversion of plasminogen to plasmin
What are the adverse effects of thrombolytic drugs?
haemorrhage
hypotension
allergic reaction
reperfusion induced arrhythmias
Describe the pathway summary for unstable angina and NSTEMI
Describe the pathway summary for STEMI